These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming. Araldi D; Bogen O; Green PG; Levine JD J Neurosci; 2019 Aug; 39(33):6414-6424. PubMed ID: 31209174 [TBL] [Abstract][Full Text] [Related]
12. Identification of versican as an isolectin B4-binding glycoprotein from mammalian spinal cord tissue. Bogen O; Dreger M; Gillen C; Schröder W; Hucho F FEBS J; 2005 Mar; 272(5):1090-102. PubMed ID: 15720384 [TBL] [Abstract][Full Text] [Related]
13. GDNF hyperalgesia is mediated by PLCgamma, MAPK/ERK, PI3K, CDK5 and Src family kinase signaling and dependent on the IB4-binding protein versican. Bogen O; Joseph EK; Chen X; Levine JD Eur J Neurosci; 2008 Jul; 28(1):12-9. PubMed ID: 18616564 [TBL] [Abstract][Full Text] [Related]
14. Peripheral inflammation selectively increases TRPV1 function in IB4-positive sensory neurons from adult mouse. Breese NM; George AC; Pauers LE; Stucky CL Pain; 2005 May; 115(1-2):37-49. PubMed ID: 15836968 [TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. Joseph EK; Chen X; Bogen O; Levine JD J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667 [TBL] [Abstract][Full Text] [Related]
16. Pericellular Griffonia simplicifolia I isolectin B4-binding ring structures in the dorsal root ganglia following peripheral nerve injury in rats. Li L; Zhou XF J Comp Neurol; 2001 Oct; 439(3):259-74. PubMed ID: 11596053 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxic targeting of isolectin IB4-binding sensory neurons. Vulchanova L; Olson TH; Stone LS; Riedl MS; Elde R; Honda CN Neuroscience; 2001; 108(1):143-55. PubMed ID: 11738138 [TBL] [Abstract][Full Text] [Related]
18. Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS). Mercadante S; Marchetti P; Cuomo A; Caraceni A; Mediati RD; Mammucari M; Natoli S; Lazzari M; Dauri M; Airoldi M; Azzarello G; Bandera M; Blasi L; Cartenì G; Chiurazzi B; Costanzo BVP; Degiovanni D; Fusco F; Guardamagna V; Iaffaioli V; Liguori S; Lorusso V; Mameli S; Mattioli R; Mazzei T; Melotti RM; Menardo V; Miotti D; Moroso S; De Santis S; Orsetti R; Papa A; Ricci S; Sabato AF; Scelzi E; Sofia M; Tonini G; Aielli F; Valle A; Adv Ther; 2017 Jan; 34(1):120-135. PubMed ID: 27873235 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones. Ahluwalia J; Urban L; Bevan S; Capogna M; Nagy I Neuroscience; 2002; 110(4):747-53. PubMed ID: 11934481 [TBL] [Abstract][Full Text] [Related]
20. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Sevcik MA; Ghilardi JR; Peters CM; Lindsay TH; Halvorson KG; Jonas BM; Kubota K; Kuskowski MA; Boustany L; Shelton DL; Mantyh PW Pain; 2005 May; 115(1-2):128-41. PubMed ID: 15836976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]